DEFINITIVE PROXY STATEMENT

Company

Ernexa Therapeutics Inc.

Filed

July 22, 1999

Period of Report

August 27, 1999

Accession Number

0000950134-99-006492

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →